New agreement is a significant commercial milestone and the Company’s first with its contract research organization partnerAgreement expands ...
On Wednesday, Jelani Nelson, a professor of theoretical computer science and chair of UC Berkeley's electrical engineering and computer science division, announced he was taking a leave of absence to ...
Adults with type 2 diabetes achieved higher time in range with the next-generation Omnipod 6 automated insulin delivery ...
The White House gathered nearly 100 participants in the Eisenhower Executive Office Building on Tuesday for a closed-door working session that marked a decisive shift in the U.S. quantum security ...
Divarasib outperformed existing therapies in patients with KRAS G12C non-small cell lung cancer (NSCLC).
A recent report in Nature describes how the Trump administration is weakening peer review in favor of ideology-based grant ...
– Multi-organ system and quality-of-life benefits sustained through five years of treatment – 82% response rate for the multi-component endpoint – 95% of patients completed five years of treatment ...
High-frequency trading firms are finally making serious inroads into FX options, more than two decades after the ...
Natera, Inc. (Nasdaq: NTRA), a global leader in cell-free DNA and precision medicine, and Eledon Pharmaceuticals, Inc. (Nasdaq: ELDN), a clinical stage biotechnology company developing ...
BMS presented trial results from mezigdomide and arlocabtagene autoleucel at EHA 2026. Credit: Tada Images/Shutterstock.com. Bristol Myers Squibb (BMS) has revealed clinical data for two pipeline ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results